Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospe... by Makoto Ohara, Hiroki Yokoyama, Hiroaki Seino, Tomoki Fujikawa, Yo Kohata, Noriyuki Takahashi, Shunichiro Irie, Michishige Terasaki, Yusaku Mori, Tomoyasu Fukui, Sho-ichi Yamagishi

Get full text

Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, ra... by Kyu Yong Cho, Hiroki Yokoyama, Tatsuya Atsumi, Hiroshi Nomoto, Jun Takeuchi, So Nagai, Yoshio Kurihara, Shin Aoki, Akinobu Nakamura, Hideaki Miyoshi, Shinji Taneda, Ichiro Sakuma, Sho Furusawa, Aika Miya, Hiraku Kameda

Get full text

Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes by Toshiharu Ninomiya, Hiroki Yokoyama, Shin-ichi Araki, Hirofumi Makino, Kunitoshi Iseki, Kengo Furuichi, Megumi Oshima, Tadashi Toyama, Takashi Wada, Miho Shimizu, Hiroyuki Nakamura, Norihiko Sakai, Yasunori Iwata, Shinji Kitajima, Akinori Hara, Yoshiki Suzuki, Hiroaki Satoh, Tetsuya Babazono, Tatsumi Moriya, Masayuki Iwano, Masakazu Haneda, Shigeko Hara, Eiji Kusano

Get full text